1. Home
  2. BRTX vs FEBO Comparison

BRTX vs FEBO Comparison

Compare BRTX & FEBO Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • BRTX
  • FEBO
  • Stock Information
  • Founded
  • BRTX 1997
  • FEBO 1993
  • Country
  • BRTX United States
  • FEBO Hong Kong
  • Employees
  • BRTX N/A
  • FEBO N/A
  • Industry
  • BRTX Managed Health Care
  • FEBO
  • Sector
  • BRTX Health Care
  • FEBO
  • Exchange
  • BRTX Nasdaq
  • FEBO Nasdaq
  • Market Cap
  • BRTX 12.5M
  • FEBO 12.6M
  • IPO Year
  • BRTX N/A
  • FEBO 2023
  • Fundamental
  • Price
  • BRTX $1.62
  • FEBO $1.06
  • Analyst Decision
  • BRTX Strong Buy
  • FEBO
  • Analyst Count
  • BRTX 1
  • FEBO 0
  • Target Price
  • BRTX $18.00
  • FEBO N/A
  • AVG Volume (30 Days)
  • BRTX 89.7K
  • FEBO 22.3K
  • Earning Date
  • BRTX 08-12-2025
  • FEBO 08-05-2025
  • Dividend Yield
  • BRTX N/A
  • FEBO N/A
  • EPS Growth
  • BRTX N/A
  • FEBO N/A
  • EPS
  • BRTX N/A
  • FEBO N/A
  • Revenue
  • BRTX $391,000.00
  • FEBO $17,110,653.00
  • Revenue This Year
  • BRTX $216.71
  • FEBO N/A
  • Revenue Next Year
  • BRTX $60.63
  • FEBO N/A
  • P/E Ratio
  • BRTX N/A
  • FEBO N/A
  • Revenue Growth
  • BRTX 161.54
  • FEBO 11.58
  • 52 Week Low
  • BRTX $1.21
  • FEBO $0.82
  • 52 Week High
  • BRTX $2.55
  • FEBO $15.48
  • Technical
  • Relative Strength Index (RSI)
  • BRTX 48.45
  • FEBO 49.81
  • Support Level
  • BRTX $1.43
  • FEBO $1.05
  • Resistance Level
  • BRTX $1.75
  • FEBO $1.07
  • Average True Range (ATR)
  • BRTX 0.12
  • FEBO 0.06
  • MACD
  • BRTX 0.01
  • FEBO 0.02
  • Stochastic Oscillator
  • BRTX 52.78
  • FEBO 79.80

About BRTX BioRestorative Therapies Inc. (NV)

BioRestorative Therapies Inc is a biotechnology company based in the United States. It focuses on the development of regenerative medicine products and therapies using cell and tissue protocols, involving adult (non-embryonic) stem cells. The company's two core development programs include the Disc/Spine Program, which involves cell therapy candidate, BRTX-100, a product formulated from autologous cultured mesenchymal stem cells collected from the patient's bone marrow; and the Metabolic Program, which includes the development of cell-based therapy to target obesity and metabolic disorders using brown adipose-derived stem cells, to generate brown adipose tissue.

About FEBO Fenbo Holdings Limited

Fenbo Holdings Ltd is a company engaged in producing premium personal care electric appliances, principally electrical hair styling products such as straighteners, curlers, trimmers, etc., and toy products to overseas markets. It manufactures and sells products such as Straightener, Mini Straightener, and Curling Iron.

Share on Social Networks: